Actuate Therapeutics Raises $9.96 Million in Stock-and-Warrant Offering
Actuate Therapeutics closed a public offering on October 28, 2026, raising approximately $9.96 million in net proceeds from common stock and warrant sales.
Actuate Therapeutics closed a public offering on October 28, 2026, raising approximately $9.96 million in net proceeds from common stock and warrant sales. The company entered into an underwriting agreement with Newbridge Securities for 30,985,900 shares and warrants to purchase up to 15,492,950 sh…